135 related articles for article (PubMed ID: 32043981)
21. Oncologic outcome after preoperative chemoradiotherapy in patients with pathologic T0 (ypT0) rectal cancer.
Jang TY; Yu CS; Yoon YS; Lim SB; Hong SM; Kim TW; Kim JH; Kim JC
Dis Colon Rectum; 2012 Oct; 55(10):1024-31. PubMed ID: 22965400
[TBL] [Abstract][Full Text] [Related]
22. Local Excision Techniques for Rectal Cancer After Neoadjuvant Chemoradiotherapy: What Are We Doing?
Smith FM; Ahad A; Perez RO; Marks J; Bujko K; Heald RJ
Dis Colon Rectum; 2017 Feb; 60(2):228-239. PubMed ID: 28059920
[TBL] [Abstract][Full Text] [Related]
23. Advances in organ preserving strategies in rectal cancer patients.
Stijns RCH; Tromp MR; Hugen N; de Wilt JHW
Eur J Surg Oncol; 2018 Feb; 44(2):209-219. PubMed ID: 29275912
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological analysis of distal margin for rectal cancer after preoperative chemoradiation therapy.
Nishioka M; Shimada M; Kurita N; Iwata T; Morimoto S; Yoshikawa K; Higashijima J; Miyatani T
Hepatogastroenterology; 2012 Oct; 59(119):2142-6. PubMed ID: 22366527
[TBL] [Abstract][Full Text] [Related]
25. Changing operative strategy from abdominoperineal resection to sphincter preservation in T3 low rectal cancer after downstaging by neoadjuvant chemoradiation: a preliminary report.
Madbouly KM; Hussein AM
World J Surg; 2015 May; 39(5):1248-56. PubMed ID: 25561197
[TBL] [Abstract][Full Text] [Related]
26. Will GRECCAR 2 be a game changer for the management of rectal cancer?
Sun Myint A; Dhadda A; Rao C; Sripadam R; Gerard JP
Colorectal Dis; 2020 Dec; 22(12):2330. PubMed ID: 32777139
[No Abstract] [Full Text] [Related]
27. Reevaluation of Preoperative Chemoradiotherapy for Clinical T3 Lower Rectal Cancer: A Multicenter Collaborative Retrospective Clinical Study.
Takeda M; Kawahara H; Ogawa M; Suwa K; Eto K; Yanaga K
Anticancer Res; 2019 Jun; 39(6):3047-3052. PubMed ID: 31177147
[TBL] [Abstract][Full Text] [Related]
28. Techniques and Outcome of Surgery for Locally Advanced and Local Recurrent Rectal Cancer.
Renehan AG
Clin Oncol (R Coll Radiol); 2016 Feb; 28(2):103-115. PubMed ID: 26683258
[TBL] [Abstract][Full Text] [Related]
29. [Therapeutic evaluation and surgical strategy after neoadjuvant chemoradiotherapy for rectal cancer].
Ma L; Wang Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Jan; 21(1):23-28. PubMed ID: 29354895
[TBL] [Abstract][Full Text] [Related]
30. [Effects of neoadjuvant chemoradiotherapy on the rates of sphincter preserving surgery in lower rectal cancer and analysis of their prognostic factors].
Wang XJ; Chi P; Lin HM; Lu XR; Huang Y; Xu ZB; Huang SH; Sun YW; Ye DX
Zhonghua Wai Ke Za Zhi; 2016 Jun; 54(6):419-423. PubMed ID: 27938574
[No Abstract] [Full Text] [Related]
31. Could a wait and see policy be justified in T3/4 rectal cancers after chemo-radiotherapy?
Hughes R; Harrison M; Glynne-Jones R
Acta Oncol; 2010 Apr; 49(3):378-81. PubMed ID: 20151936
[TBL] [Abstract][Full Text] [Related]
32. [Long-term prognostic analysis on complete/near-complete clinical remission for mid-low rectal cancer after neoadjuvant chemoradiotherapy].
Wang L; Li S; Zhang X; Sun T; Du C; Chen N; Peng Y; Yao Y; Zhan T; Zhao J; Cai Y; Li Y; Wang W; Li Z; Sun Y; Ji J; Wu A
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Nov; 21(11):1240-1248. PubMed ID: 30506534
[TBL] [Abstract][Full Text] [Related]
33. Locally advanced rectal cancer: Preliminary results of rectal preservation after neoadjuvant chemoradiotherapy.
Vaccaro CA; Yazyi FJ; Ojra Quintana G; Santino JP; Sardi ME; Beder D; Tognelli J; Bonadeo F; Lastiri JM; Rossi GL
Cir Esp; 2016 May; 94(5):274-9. PubMed ID: 26980259
[TBL] [Abstract][Full Text] [Related]
34. Can less be more? Organ preservation strategies in the management of rectal cancer.
Rouleau-Fournier F; Brown CJ
Curr Oncol; 2019 Nov; 26(Suppl 1):S16-S23. PubMed ID: 31819706
[TBL] [Abstract][Full Text] [Related]
35. Long-term outcome of local excision after preoperative chemoradiation for ypT0 rectal cancer.
Stipa F; Picchio M; Burza A; Soricelli E; Vitelli CE
Dis Colon Rectum; 2014 Nov; 57(11):1245-52. PubMed ID: 25285690
[TBL] [Abstract][Full Text] [Related]
36. Neoadjuvant therapy and transanal endoscopic surgery in T2-T3 superficial, N0, M0 rectal tumors. Local recurrence, complete clinical and pathological response.
Serra-Aracil X; Pericay C; Mora-Lopez L; Garcia Pacheco JC; Latorraca JI; Ocaña-Rojas J; Casalots A; Ballesteros E; Navarro-Soto S
Cir Esp; 2017 Apr; 95(4):199-207. PubMed ID: 28411888
[TBL] [Abstract][Full Text] [Related]
37. Pre-operative chemoradiation for non-metastatic locally advanced rectal cancer.
McCarthy K; Pearson K; Fulton R; Hewitt J
Cochrane Database Syst Rev; 2012 Dec; 12():CD008368. PubMed ID: 23235660
[TBL] [Abstract][Full Text] [Related]
38. MRI and diffusion-weighted MRI to diagnose a local tumour regrowth during long-term follow-up of rectal cancer patients treated with organ preservation after chemoradiotherapy.
Lambregts DM; Lahaye MJ; Heijnen LA; Martens MH; Maas M; Beets GL; Beets-Tan RG
Eur Radiol; 2016 Jul; 26(7):2118-25. PubMed ID: 26518582
[TBL] [Abstract][Full Text] [Related]
39. Feasibility of Transanal Local Excision Following Chemoradiation for Lower Rectal Cancer.
Tokunaga T; Nishi M; Higashijima J; Yoshikawa K; Kashihara H; Takasu C; Ishikawa D; Bando Y; Shimada M
Anticancer Res; 2017 Oct; 37(10):5617-5622. PubMed ID: 28982878
[TBL] [Abstract][Full Text] [Related]
40. A systematic review of local excision combined with chemoradiotherapy for early rectal cancer.
Ung L; Chua TC; Engel AF
Colorectal Dis; 2014 Jul; 16(7):502-15. PubMed ID: 24605870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
